Roadmap toward a neuromodulatory treatment for PTSD and anxiety
Society of Clinical Psychology
AUGUST 15, 2023
2011), allowing researchers to target both hyper and hypo active circuits associated with a particular symptom or disorder. This flexibility has allowed researchers to develop several FDA-approved TMS treatments for depression (O’Reardon et al., 2007a), obsessive compulsive disorder (Carmi et al., 1994; Grillon, 2008a; Morgan et al.,
80 
Let's personalize your content